Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29275527 | 0.93 | — | — | |
| SCHEMBL30415739 | 0.85 | USP2 (0.33) | OPRK1 | |
| SCHEMBL25215465 | 0.85 | USP2 (0.33) | OPRK1 | |
| SCHEMBL25197921 | 0.85 | USP2 (0.32) | — | |
| SCHEMBL29275511 | 0.85 | — | — | |
| SCHEMBL25203578 | 0.82 | OPRK1 (0.31) | OPRK1 | |
| SCHEMBL29275521 | 0.82 | LMNA (0.33) | OPRK1 | |
| SCHEMBL29275519 | 0.82 | SMN1; SMN2 (0.32) | OPRK1 | |
| SCHEMBL31348280 | 0.78 | OPRK1 (0.35) | OPRK1 | |
| SCHEMBL25199449 | 0.73 | USP2 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4405323-B1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH & CIE (CH) | 2026-01-14 | — | — | EP | disclosed |
| US-20250034074-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH SA (CH) | 2025-01-30 | — | — | US | disclosed |
| EP-4405323-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | Firmenich SA (CH) | 2024-07-31 | — | — | EP | disclosed |
| CN-118302402-A | Process for the preparation of cyclic dienes | 弗门尼舍有限公司 | 2024-07-05 | — | — | CN | disclosed |
| WO-2023094502-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | FIRMENICH SA (CH) | 2023-06-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250034074-A1 | PROCESS FOR PREPARING A CYCLIC DIENE | DHPS, FDFT1, CYP17A1 | OPRK1 2311/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.